CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

Eun Kyoung Jeon, Sook Hee Hong, Tae Hee Kim, Seung Eun Jung, Ji Chan Park, Hye-Sung Won, Yoon-Ho Ko, Sang Young Rho, Young Seon Hong

Cancer Research and Treatment. 2011;43(3):148-153. Published online 2011 September 30 DOI: https://doi.org/10.4143/crt.2011.43.3.148

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

Eun Kyoung Jeon, Sook Hee Hong, Tae Hee Kim, Seung Eun Jung, Ji Chan Park, Hye-Sung Won, Yoon-Ho Ko, Sang Young Rho, Young Seon Hong

Cancer Research and Treatment. 2011;43(3):148-153

Link1

Link2

P-0025 Modified Folfiri (mFolfiri) as Second Line Chemotherapy in Advanced Gastric Cancer (AGC)

Arslane Rahal, Valerie Boige, Malka David, Chahinez Rahal, Pascal Burtin, Isabelle Sinapi, Dominique Elias, Diane Goere, Benjamin Lacas, Michel Ducreux

Annals of Oncology. 2012;23:iv38

Link1 Link2

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐line treatment regimen for unresectable pancreatic cancer: A real‐world analysis

Shun Tezuka, Makoto Ueno, Ritsuko Oishi, Shuhei Nagashima, Yusuke Sano, Kuniyuki Kawano, Satoshi Tanaka, Taito Fukushima, Hiroyuki Asama, Naoki Konno, Satoshi Kobayashi, Manabu Morimoto, Shin Maeda

Cancer Medicine. 2021;11(4):1088-1098

Link1 Link2 Link3

Su1959 Efficacy and Safety of FOLFIRI After Failure of FOLFOX-4 in Advanced Gastric Cancer

Moo In Park, Seun Ja Park, Won Moon, Hyung Hun Kim, Hae-Won Lee

Gastroenterology. 2013;144(5):S-519

Link1 Link2

A randomized trial of FOLFIRI versus docetaxel and cisplatin as a second-line chemotherapy after failure of first-line chemotherapy in advanced gastric cancer

Kil Lee Sang, Seok Moon Hee, Eun Kim Sung, seok jang jin, Young Cho Joo, Sun Kim Eun, Hyung Lee Si, Chul Park Jun, Kang Lee Yong

Annals of Oncology. 2017;28:iii34

Link1 Link2 Link3

Efficacy and Safety of FOLFIRI as Second-line Chemotherapy in Advanced Gastric Cancer

Sung Chul Park, Hoon Jai Chun

The Korean Journal of Gastroenterology. 2015;66(1):1

Link1 Link2 Link3

P-52 FOLFIRI or FOLFOX in second line of advanced biliary tract cancer: A retrospective analysis

M. Balarine, T. Felismino, M. Camandaroba

Annals of Oncology. 2022;33:S265

Link1 Link2

A Multi-Center Phase II Study and Predictive Biomarker Analysis of Combined Cetuximab and Modified Folfiri as Second-Line Treatment in Patients with Metastatic Gastric Cancer

L. Jin

Annals of Oncology. 2012;23:ix233

Link1 Link2

Second-line FOLFOX chemotherapy for advanced biliary tract cancer

Fangqiang Wei

The Lancet Oncology. 2021;22(7):e284

Link1 Link2

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

C Yoo, J Y Hwang, J-E Kim, T W Kim, J S Lee, D H Park, S S Lee, D W Seo, S K Lee, M-H Kim, D J Han, S C Kim, J-L Lee

British Journal of Cancer. 2009;101(10):1658-1663

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.